Modulate Bio Inc.

Modulate Bio Inc.

Private
MassachusettsHealthcare & Life Scienceshttps://www.modulatebio.com/

Last Round

Seed Round

Apr 7, 2026

Total Funding Raised

$660,000

Momentum Score

25 /100

Company Overview

Modulate Bio Inc. is a biotechnology company developing novel, differentiated GABAA positive allosteric modulators to treat neurological disorders including Essential Tremor, epilepsy, and anxiety.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Medical AI, Mental Health

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

positive allosteric modulatorsPAMssmall molecule therapiesGABA-A modulatorsneurological disordersneurotherapeuticsEssential Tremordrug discovery platformcomputational drug discoveryin-silico drug discoveryCNS disorderspreclinical biotechdrug licensingepilepsyanxiety

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Modulate Bio Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Modulate Bio Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Seed RoundApr 7, 2026
SeedJun 12, 2025
GrantJan 1, 2024
AcceleratorDec 13, 2023

Key People

Founding team and executive leadership

Andrew Thomson

Ipsen BD I, CEO Co-founder

Founding Team

Modulate Bio Inc. Investors

Notable investors and investment history

InvestorRounds
Bija VenturesSeed Round
Harvard Innovation LabsGrant
Pillar VCSeed Round, Accelerator, Seed
Blavatnik Fellowship in Life Science EntrepreneurshipGrant
NovaterraSeed Round, Seed
NucleateAccelerator
Palo Santo Venture FundSeed Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 7, 2026

    $785K raised in Seed Round funding.

  • Jan 21, 2026

    Monthly visitors increased 856% MoM, from 131 to 1.3K.

Modulate Bio Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Modulate Bio Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Modulate Bio Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersMassachusetts
Employee Range5
Year Founded2023
Last FundingApr 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.